CLINICAL_TRIALS
trial_result
· 2022-07-13
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]
Summary
A Phase 2 clinical trial evaluating vamorolone for Duchenne muscular dystrophy has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ReveraGen BioPharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2022-07-13